Small molecule inhibitors of bromdomain BET family of chromatin adaptor proteins have shown promising therapeutic effect in acute myeloid leukemia, multiple myeloma and Burkitt’s lymphoma [4-7]. This evidence concerns the gene DNER and plasma cell myeloma.